Healthcare >> CEO Interviews >> June 10, 2005

Lisa Drakeman – Genmab A/s (gen.cse)

TWST: We'd ask you for that entry point, what is Genmab?

Dr. Drakeman: Genmab is a biotechnology company focused on developing

human antibodies for a wide variety of diseases including cancer